Francisco Averhoff
Overview
Explore the profile of Francisco Averhoff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
908
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vaman R, Solomon S, Averhoff F, Landay A, Thangaraj J, Suliankatchi Abdulkader R, et al.
Indian J Med Res
. 2025 Mar;
161(1):54-63.
PMID: 40036102
Background & objectives Event-based surveillance (EBS) is a critical component of early warning systems for detecting and responding to infectious disease outbreaks. While EBS is widely used in public health...
2.
Gubareva U, Horth R, Nabirova D, Tukhanova N, Utegenova E, Shapiyeva Z, et al.
Front Public Health
. 2025 Jan;
12:1519117.
PMID: 39886389
Background: Orthohantaviruses (also known as hantaviruses) are pathogens, primarily transmitted by rodents, that can cause hemorrhagic fever with renal syndrome (HFRS). In endemic regions of Kazakhstan, no confirmed HFRS cases...
3.
Maya M, Ortiz C, Averhoff F, Carabali M, Perez-Restrepo L, Ciuoderis-Aponte K, et al.
Front Epidemiol
. 2025 Jan;
4:1519378.
PMID: 39868356
Objectives: Surveillance of acute respiratory infection (ARI) informs vaccination, preventive, and management decisions. In many countries, immunofluorescence is the cornerstone for ARI surveillance. We aimed to determine the effect of...
4.
Bbosa N, Ssemwanga D, Weiss S, Kalungi S, Mawanda A, Ssentudde R, et al.
Am J Trop Med Hyg
. 2025 Jan;
PMID: 39773989
Between April and November 2023, 27 unexplained human deaths that presented with swelling of the arms, skin sores with black centers, difficulty in breathing, obstructed swallowing, headaches, and other body...
5.
Qureshi H, Mahmood H, Nasir Z, Siddique S, Averhoff F, Cloherty G
J Viral Hepat
. 2024 May;
31(8):500-503.
PMID: 38771312
Hepatitis C virus core antigen (HCVcAg) testing can simplify and decrease costs of HCV infection confirmation compared to molecular testing (nucleic acid testing). We piloted HCVcAg testing for the confirmation...
6.
Orf G, Ahouidi A, Mata M, Diedhiou C, Mboup A, Padane A, et al.
Front Microbiol
. 2024 Apr;
15:1362714.
PMID: 38655084
Introduction: Acute febrile illnesses (AFI) in developing tropical and sub-tropical nations are challenging to diagnose due to the numerous causes and non-specific symptoms. The proliferation of rapid diagnostic testing and...
7.
Khetsuriani N, Gamkrelidze A, Shadaker S, Tsereteli M, Alkhazashvili M, Chitadze N, et al.
Euro Surveill
. 2023 Jul;
28(30).
PMID: 37498531
BackgroundGeorgia has adopted the World Health Organization European Region's and global goals to eliminate viral hepatitis. A nationwide serosurvey among adults in 2015 showed 2.9% prevalence for hepatitis B virus...
8.
Baliashvili D, Blumberg H, Gandhi N, Averhoff F, Benkeser D, Shadaker S, et al.
PLoS Med
. 2023 May;
20(5):e1004121.
PMID: 37141386
Background: The Eastern European country of Georgia initiated a nationwide hepatitis C virus (HCV) elimination program in 2015 to address a high burden of infection. Screening for HCV infection through...
9.
Gvinjilia L, Baliashvili D, Shadaker S, Averhoff F, Kandelaki L, Kereselidze M, et al.
Clin Infect Dis
. 2023 Apr;
77(3):405-413.
PMID: 37099136
Background: Mortality related to hepatitis C virus (HCV) infection is a key indicator for elimination. We assessed the impact of HCV infection and treatment on mortality in the country of...
10.
Gamkrelidze A, Shadaker S, Tsereteli M, Alkhazashvili M, Chitadze N, Tskhomelidze I, et al.
J Infect Dis
. 2023 Mar;
228(6):684-693.
PMID: 36932731
Background: The country of Georgia initiated its hepatitis C virus (HCV) elimination program in 2015, at which point a serosurvey showed the adult prevalence of HCV antibody (anti-HCV) and HCV...